History

Taro Pharmaceutical Industries is before: A leading pharmaceutical company operating since 1950, setting a high standard of quality, reliability, and medical innovation.

1950

Taro manufacturing facility established in Israel for production of finished pharmaceutical products

1961

Production of active pharmaceutical ingredients (API) for Taro products in Israel

1984

Acquisition of creams and ointments manufacturing facility in Canada

1988

Entry into the American market

2003

Establishment of branded products division

2006

Launch of advanced manufacturing facilities at Taro Israel

2010

Taro was acquired by Sun Pharma

2012

Over $1 billion gross

2012

Company IPO on NYSE

2016

Taro from Sun Pharma Group - the leading generic dermatology company in the USA

2022

Taro from Sun Pharma Group completes acquisition of Alkemi

2024

2024 - On June 24, 2024, Taro became a private company and a wholly-owned subsidiary of Sun Pharma, and its shares ceased trading on the New York Stock Exchange.

Contact Us

Taro Pharmaceutical Industries Ltd.
(A Sun Pharma Company)

14 Hakitor Street, PO Box 10347
Haifa Bay, 2624761, Israel

Telephone: +972-4-8475700